Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Argos Therapeutics Inc (ARGS)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Argos Therapeutics Inc.
Table 2 shows the detailed insider transactions.
This company's CIK number is 1105533.
Total stock buying since 2015: $2,578,071.
Total stock sales since 2015: $162,371.
Total stock option exercises since 2015: $0.
Table 3. Detailed insider trading at Argos Therapeutics Inc (ARGS)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2018-01-09 | Nicolette Charles A. (CSO and Vice President of R&D) | Sale | 100,250 | .17 | 16,541 |
| 2018-01-09 | Abbey Jeffrey D (President, CEO) | Sale | 124,987 | .17 | 20,622 |
| 2018-01-09 | Harrelson Lori R. (Vice President of Finance) | Sale | 64,329 | .17 | 10,614 |
| 2018-01-09 | Katz Richard D (Vice President and CFO) | Sale | 104,435 | .17 | 17,231 |
| 2018-01-03 | Nicolette Charles A. (CSO and Vice President of R&D) | Sale | 92,001 | .16 | 15,088 |
| 2018-01-03 | Abbey Jeffrey D (President, CEO) | Sale | 229,404 | .16 | 37,392 |
| 2018-01-03 | Harrelson Lori R. (Vice President of Finance) | Sale | 59,072 | .16 | 9,687 |
| 2018-01-03 | Katz Richard D (Vice President and CFO) | Sale | 101,228 | .16 | 16,500 |
| 2016-10-07 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 21,000 | 4.73 | 99,330 |
| 2016-10-06 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 2,640 | 4.81 | 12,698 |
| 2016-10-05 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 900 | 4.85 | 4,365 |
| 2016-10-04 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 7,164 | 4.69 | 33,599 |
| 2016-10-03 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 11,308 | 4.70 | 53,147 |
| 2016-09-30 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 30,232 | 4.71 | 142,392 |
| 2016-09-29 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 15,100 | 4.60 | 69,460 |
| 2016-09-28 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 28,518 | 4.54 | 129,471 |
| 2016-09-20 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 41,259 | 4.77 | 196,805 |
| 2016-09-19 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 5,580 | 4.76 | 26,560 |
| 2016-09-16 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 36,632 | 4.78 | 175,100 |
| 2016-09-15 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 15,880 | 4.76 | 75,588 |
| 2016-09-01 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 16,977 | 4.78 | 81,150 |
| 2016-08-24 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 112,996 | 4.56 | 515,235 |
| 2016-08-23 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 9,599 | 4.36 | 41,851 |
| 2016-08-22 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 21,950 | 4.26 | 93,507 |
| 2016-08-19 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 53,524 | 4.23 | 226,406 |
| 2016-08-02 | Forargos B.v. (10% Owner) | Buy | 1,545,454 | .00 | 0 |
| 2016-08-02 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 2,363,636 | .00 | 0 |
| 2016-08-02 | Van Deventer Sander (Director) | Buy | 1,545,454 | .00 | 0 |
| 2016-06-29 | Forargos B.v. (10% Owner) | Buy | 1,322,618 | .00 | 0 |
| 2016-06-29 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 2,678,301 | .00 | 0 |
| 2016-06-29 | Van Deventer Sander (Director) | Buy | 1,322,618 | .00 | 0 |
| 2016-06-29 | Birner Hubert (Director) | Buy | 275,545 | .00 | 0 |
| 2016-03-14 | Public Joint Stock Co Pharmstandard (10% Owner) | Buy | 1,785,534 | .00 | 0 |
| 2016-03-14 | Van Deventer Sander (Director) | Buy | 881,745 | .00 | 0 |
| 2016-03-14 | Birner Hubert (Director) | Buy | 183,697 | .00 | 0 |
| 2015-12-16 | Petrov Andrei Vladimirovich (Director) | Buy | 5,000 | 1.80 | 9,000 |
| 2015-12-16 | Winterbottom Joan (Chief Human Resources Officer) | Buy | 250 | 1.83 | 457 |
| 2015-12-15 | Vinogradov Alexey Alexandrovich (Director) | Buy | 2,000 | 2.15 | 4,300 |
| 2015-12-14 | Winterbottom Joan (Chief Human Resources Officer) | Buy | 250 | 2.15 | 536 |
| 2015-12-14 | Abbey Jeffrey D (CEO) | Buy | 5,000 | 2.50 | 12,485 |
| 2015-12-02 | Abbey Jeffrey D (CEO) | Buy | 1,000 | 3.89 | 3,889 |
| 2015-11-24 | Van Holle Philippe Marie Marcel Joseph (Director) | Buy | 10,000 | 4.28 | 42,750 |
| 2015-11-19 | Van Holle Philippe Marie Marcel Joseph (Director) | Buy | 10,000 | 4.15 | 41,510 |
| 2015-11-19 | Abbey Jeffrey D (CEO) | Buy | 1,000 | 4.08 | 4,080 |
| 2015-09-03 | Van Holle Philippe Marie Marcel Joseph (Director) | Buy | 6,000 | 6.31 | 37,842 |
| 2015-09-02 | Van Holle Philippe Marie Marcel Joseph (Director) | Buy | 6,000 | 6.22 | 37,344 |
| 2015-09-01 | Van Holle Philippe Marie Marcel Joseph (Director) | Buy | 5,000 | 6.26 | 31,320 |
| 2015-08-25 | Lamarre Jean (Director) | Buy | 2,500 | 6.14 | 15,352 |
| 2015-08-24 | Winterbottom Joan (Chief Human Resources Officer) | Buy | 1,000 | 6.09 | 6,095 |
| 2015-08-20 | Van Holle Philippe Marie Marcel Joseph (Director) | Buy | 5,000 | 5.80 | 29,025 |
| 2015-08-20 | Nicolette Charles A. (Chief Scientific Officer) | Buy | 5,000 | 6.45 | 32,250 |
| 2015-08-19 | Van Holle Philippe Marie Marcel Joseph (Director) | Buy | 3,100 | 4.73 | 14,653 |
| 2015-08-19 | Abbey Jeffrey D (CEO) | Buy | 5,500 | 4.75 | 26,146 |
Insider trading activities including stock purchases, stock sales, and option exercises
of ARGS listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Argos Therapeutics Inc (symbol ARGS,
CIK number 1105533) see
the Securities and Exchange Commission (SEC) website.